http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112933205-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d03c1c49865fbfc8bc0f8d9501f13372
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2236-333
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2236-331
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2236-51
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2236-53
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2236-39
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-65
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-57
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-537
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-54
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-484
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0004
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0014
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-481
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-9068
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-324
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-896
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-286
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-708
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-744
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-258
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-238
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-232
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-236
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-758
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-17
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-486
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-328
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-185
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-736
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-11
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-71
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P13-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-9068
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-16
filingDate 2021-01-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_158c20bc0199105f9d31314177455031
publicationDate 2021-06-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-112933205-A
titleOfInvention A kind of pharmaceutical composition for treating osteoarthritis and preparation method thereof
abstract The invention discloses a pharmaceutical composition for treating osteoarthritis and a preparation method thereof. The pharmaceutical composition is prepared from the following raw material components in parts by weight: 10-20 parts of gardenia, 10-30 parts of angelica, 10-20 parts of rhubarb, 10-40 parts of salvia, 10-30 parts of Chuanxiong, 10-20 parts of dried dragon's blood, 10-30 parts of licorice, 10-25 parts of angelica, 10-30 parts of ephedra, 10-30 parts of cassia twig , 10-20 parts of parsnip, 10-30 parts of Scarlet vine, 5-20 parts of white peony, 15-40 parts of safflower, 5-20 parts of myrrh, 10-20 parts of frankincense, 10-25 parts of star anise, 5-15 parts of Bone Grass, 5-20 parts of Elongatus, 10-30 parts of Astragalus, 10-30 parts of Xanthium, 10-20 parts of Chuan Duan, 10-20 parts of ginger, 10-30 parts of Panax notoginseng, peach kernel 10-30 servings, 10-25 double-sided acupuncture, the pharmaceutical composition follows the principle of compatibility of the monarch, minister, assistant and envoy, and selects the drug formula, which has the effects of promoting blood circulation and regulating qi, strengthening tendons and bones, dispelling blood stasis and promoting blood circulation, clearing meridians and activating collaterals, etc., and the drug combination The compound has no damage to the human body, simple preparation, wide drug sources, low cost, significant curative effect and no toxic and side effects, and can effectively treat osteoarthritis disease.
priorityDate 2021-01-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419483452
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538410
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14982
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID702
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419527139
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID753
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962

Total number of triples: 67.